Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Egorin

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941D I Jodrell, L S Murray, J Hawtof, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suraminR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Cancer Treatment Reports|December 1, 1985
Doxorubicin and cisplatin excretion into human milkP C Egan, M E Costanza, P Dodion, et al.
The Journal of Biological Chemistry|February 10, 1979
Phaseolus vulgaris isolectin binding to human erythrocytesM J Egorin, S Z Bachur, R L Felsted, et al.
Cancer Research|June 1, 1978
Inhibitory effects of phytohemagglutinin isolectins L4 and E4 on L1210 cellsM J Egorin, R N Odders, F T Sanel, et al.
Chemical Research in Toxicology|January 1, 1992
Alkylation of DNA with aziridine produced during the hydrolysis of N,N',N''-triethylenethiophosphoramideS M Musser, S S Pan, M J Egorin, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical and pharmacologic trial of carboplatin daily for 5 daysD A Van Echo, M J Egorin, M Y Whitacre, et al.
Cancer Letters|August 15, 1988
Cellular pharmacology of N,N',N''-triethylene thiophosphoramideB Miller, T Tenenholz, M J Egorin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1979
Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agentM J Egorin, R E Clawson, J L Cohen, et al.
IARC Scientific Publications|January 1, 1988
DNA adducts of cisplatin and carboplatin in tissues of cancer patientsM C Poirier, M J Egorin, A M Fichtinger-Schepman, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|January 1, 1996
A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941D I Jodrell, L S Murray, J Hawtof, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suraminR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Cancer Treatment Reports|December 1, 1985
Doxorubicin and cisplatin excretion into human milkP C Egan, M E Costanza, P Dodion, et al.
The Journal of Biological Chemistry|February 10, 1979
Phaseolus vulgaris isolectin binding to human erythrocytesM J Egorin, S Z Bachur, R L Felsted, et al.
Cancer Research|June 1, 1978
Inhibitory effects of phytohemagglutinin isolectins L4 and E4 on L1210 cellsM J Egorin, R N Odders, F T Sanel, et al.
Chemical Research in Toxicology|January 1, 1992
Alkylation of DNA with aziridine produced during the hydrolysis of N,N',N''-triethylenethiophosphoramideS M Musser, S S Pan, M J Egorin, et al.
Cancer Treatment Reports|September 1, 1984
Phase I clinical and pharmacologic trial of carboplatin daily for 5 daysD A Van Echo, M J Egorin, M Y Whitacre, et al.
Cancer Letters|August 15, 1988
Cellular pharmacology of N,N',N''-triethylene thiophosphoramideB Miller, T Tenenholz, M J Egorin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1979
Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agentM J Egorin, R E Clawson, J L Cohen, et al.
IARC Scientific Publications|January 1, 1988
DNA adducts of cisplatin and carboplatin in tissues of cancer patientsM C Poirier, M J Egorin, A M Fichtinger-Schepman, et al.
Pageof 16